Abiopharma

New Form 8-K - Sarepta Therapeutics, Inc. Filed: 2025-07-16 AccNo: 0000950170-25-096257 Size: 284 KB Item 2.02: Results of Operations and Financial Condition Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits